Keyphrases
Radiopharmaceutical Therapy
75%
Disseminated Tumor Cells
50%
Patient-specific Treatment
25%
Radionuclides
24%
Micrometastasis
24%
Primary Tumor
24%
Radiopharmaceuticals
24%
Relative Biological Effectiveness
24%
Treatment Planning
12%
Tumor Metastasis
12%
Educational Component
12%
Cell Killing
12%
Therapeutic Effect
12%
Response Predictors
12%
Microscopic Disease
12%
Xofigo
12%
Disease-based
12%
Activity Distribution
12%
DOTATATE
12%
Cancer Cells
12%
Therapeutic Efficacy
12%
Dosimetry
12%
Radium-223
12%
External Beam
12%
Educational Tool
12%
External Beam Radiotherapy
12%
Successful Implementation
12%
Commercial Tools
12%
Metastasis
12%
Design Planning
12%
Lutetium-177 (177Lu)
12%
Radiobiology
12%
Auger Emitters
12%
Therapeutic Design
12%
Therapy Treatment
12%
US FDA
12%
Medicine and Dentistry
Radiopharmaceutical Agent
100%
Metastatic Carcinoma
81%
Micrometastasis
43%
Dosimetry
34%
Treatment Planning
34%
Radiation Biology
34%
Radium Chloride Ra 223
18%
Relative Biologic Effectiveness
18%
Disease
18%
Weakness
18%
Radioisotope
18%
Primary Tumor
18%
Therapy Effect
9%
Combination Therapy
9%
Malignant Neoplasm
9%
Cell Killing
9%
External Beam Radiotherapy
9%
Lutetium 177
9%
Cancer Cell
9%
Pharmacology, Toxicology and Pharmaceutical Science
Radiopharmaceutical Agent
100%
Metastasis
71%
Micrometastasis
43%
Dosimetry
34%
Malignant Neoplasm
18%
Radioisotope
18%
Radium Chloride Ra 223
18%
Primary Tumor
18%
Disease
18%
Weakness
18%
Combination Therapy
9%
Lutetium 177
9%
Therapeutic Effect
9%